• Entry
  • Reader's guide
  • Entries A-Z
  • Subject index

Fen-Phen (Fenfluramine/Phentermine) Controversy

The term Fen-Phen refers to the use in combination of fenfluramine (Pondimin) and phentermine, although the latter has also been used with dexfenfluramine (Redux). Both fenfluramine and dexfenfluramine were approved only as appetite suppressants for the management of obesity, yet physicians began to prescribe them in combination with phentermine (a stimulant), a method that is called “off-label use.” Both fenfluramine and dexfenfluramine work by releasing into the body extra amounts of serotonin, a chemical linked to various brain functions, including a feeling of satiety.

The U.S. Food and Drug Administration (FDA) originally approved phentermine in 1959, whereas fenfluramine was approved in 1973. In 1996, dexfenfluramine, manufactured by Interneuron Pharmaceuticals and marketed by Wyeth-Ayerst Laboratories (a subsidiary of American Home Products Corp.), was approved for use ...

    • Loading...
    locked icon

    Sign in to access this content

    Get a 30 day FREE TRIAL

    • Watch videos from a variety of sources bringing classroom topics to life
    • Read modern, diverse business cases
    • Explore hundreds of books and reference titles